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Abstract
A well-balanced human diet includes a significant intake of non-starch polysaccharides, 
collectively termed “ dietary fibre,”  from the cell walls of diverse fruits and vegetables.1 Due to a 
paucity of alimentary enzymes encoded by the human genome,2 our ability to derive energy from 
dietary fibre depends on saccharification and fermentation of complex carbohydrates by the 
massive microbial community residing in our distal gut.3,4 The xyloglucans (XyGs), in particular, 
are a ubiquitous family of highly branched plant cell wall polysaccharides5,6 whose mechanism(s) 
of degradation in the human gut and consequent importance in nutrition was heretofore 
unknown.1,7,8 Here, we demonstrate that a single, complex gene locus in Bacteroides ovatus 
confers xyloglucan catabolism in this common colonic symbiont. Through targeted gene 
disruption, biochemical analysis of all predicted glycoside hydrolases and carbohydrate-binding 
proteins, and three-dimensional structural determination of the vanguard endo-xyloglucanase, we 
reveal the molecular mechanisms through which XyGs are hydrolysed to component 
monosaccharides for further metabolism. We also observe that orthologous xyloglucan utilization 
loci (XyGULs) serve as genetic markers of xyloglucan catabolism in Bacteroidetes, that XyGULs 
are restricted to a limited number of phylogenetically diverse strains, and that XyGULs are 
ubiquitous in surveyed human metagenomes. Our findings reveal that the metabolism of even 
highly abundant components of dietary fibre may be mediated by niche species, which has 
immediate fundamental and practical implications for gut symbiont population ecology in the 
context of human diet, nutrition and health.9–12
Despite our omnivory, a census of the glycoside hydrolases (GH) encoded by the human 
genome indicates that our inherent ability to digest carbohydrates is restricted to starch and 
simple saccharides, e.g. malto-oligosaccharides, sucrose and lactose.2 Consequently, the 
human gut microbiota and its cohort of predicted carbohydrate-active enzymes are 
implicated in the conversion of otherwise indigestible plant polysaccharides to short-chain 
fatty acids,2,7,13 which provides up to 10% of the daily caloric intake in humans14,15 and is 
central to colonic heath.4,9,11,16 Despite an increasing body of (meta)genomic sequence 
data,13,17–20 the enzymatic pathways by which the most common dietary polysaccharides 
are digested in the human gut have not been elucidated.7,13
XyGs are widespread in the vegetables we consume: Dicot primary cell walls, for example 
those of lettuce, onions and tomatoes, may contain up to 25% XyG on a dry-weight 
basis.1,5,6 The primary walls of commelinoid monocots, including the cereals, contain much 
lower (1–5%) – but still non-zero – amounts of XyGs.1,6 Seed XyGs are also widely used as 
food thickening agents and have been employed as drug delivery matrices in the intestine.21 
This family of polysaccharides is typified by a Ś(1ў4)-glucan main chain that is heavily 
substituted with pendant ř(1ў6)-linked xylosyl units. Depending on the species and tissue 
of origin, these branches may be further extended by additional monosaccharides, including 
galactose, fucose, and/or arabinose (Figure 1).5,22 As such, complete saccharification in the 
gut necessarily requires a cadre of enzymes to address the monosaccharide and linkage 
diversity of these complex polysaccharides.
We recently identified a polysaccharide utilization locus (PUL) in the genome of a common 
human gut symbiont B. ovatus, but not in the closely related model species B. 
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thetaiotaomicron,17 that was transcriptionally up-regulated in response to growth on 
galactoxyloglucan.7 By homology with the archetypal starch utilization system (Sus) of B. 
thetaiotaomicron, this PUL was predicted to encode an outer membrane sugar-binding 
protein (SusD-like), a TonB-dependent sugar receptor/transporter (SusC-like), and an inner 
membrane hybrid two-component sensor. Further analysis strikingly revealed that this PUL 
was also predicted to encode eight glycoside hydrolases (GHs) from six enzyme families 
(Figure 2), which tantalizingly suggested a collective role in XyG utilization by B. ovatus. 
To establish a direct causal link for growth on XyG7,8 and outline a pathway for its 
degradation, we performed an in-depth molecular characterization of the PUL through 
reverse genetics, in vitro protein biochemistry and enzymology, and structural biology.
A mutant strain of B. ovatus harbouring a targeted deletion of the complete predicted 
xyloglucan utilization locus (XyGUL, Figure 2) was indeed completely unable to grow on 
tamarind XyG as the sole carbon source, but was otherwise phenotypically identical to the 
wild-type strain (data not shown). This indicated an absolute requirement for one or more of 
the corresponding gene products in XyG catabolism. Subsequently, all eight predicted GHs 
were produced recombinantly in E. coli and subjected to detailed enzymatic characterization 
to establish their substrate specificities and reaction products (Extended Data Table ED1, 
Supplementary Figures S1–20). All enzymes were maximally active in the pH range 6.0–
7.0, which is consistent with function in the distal human gut (Supplementary Figures S1–6).
Reducing-sugar assays and mass spectrometry (MS) demonstrated that the recombinant 
BoGH5A and BoGH9A enzymes were versatile endo-xyloglucanases, which cleaved the 
backbone of the three major types of natural xyloglucans, i.e. seed galactoxyloglucan from 
tamarind kernel, dicot fucogalactoxyloglucan from lettuce leaves, and solanaceous 
arabinogalactoxyloglucan from tomato fruit, to produce xyloglucan oligosaccharides 
(XyGOs) based on a Glc4 backbone (Extended Data Table ED1 and Supplementary Figures 
S7–10, cf. Figure 1). Assays on chromogenic aryl Ś-glycosides of XyGOs and natural 
XyGOs, together with product analyses, revealed the following exo-specificities for the 
remaining XyGUL enzymes: BoGH2A, Ś-galactosidase; BoGH3A and BoGH3B, Ś-
glucosidase; BoGH31A ř-xylosidase; BoGH43A and BoGH43B, ř-L-arabinofuranosidase 
(Extended Data Table ED1, Supplementary Data Figures S11–20). This profile of activities, 
together with phenotypic data from additional gene-specific knock-out strains (Extended 
Data Table ED2), allowed us to outline a complete model of XyG degradation by B. ovatus 
(Figure 3).
Analogous to the endo-amylase SusG of the B. thetaiotaomicron starch utilization system,4 
the vanguard role in XyG utilization by B. ovatus is performed by the versatile endo-
xyloglucanase BoGH5A, which generates short XyGOs for uptake (Figure 3). Indeed, a 
gene-specific knock-out of BoGH5A rendered B. ovatus incapable of growth on XyG 
polysaccharide, but this phenotype could be directly rescued by the addition of XyGOs 
produced exogenously by recombinant BoGH5A (Extended Data Table ED2, cf. 
Supplementary Figure S8). In contrast, a gene-specific knock-out of BoGH9A had no effect 
on growth (Extended Data Table ED2), consistent with the observation that although this 
enzyme produced the same limit digestion products from all XyGs as BoGH5, BoGH9A was 
catalytically feeble with kinetics too slow to be quantified (Extended Data Table ED1, 
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Supplementary Figure S8–10). That a corresponding GH9 member is not found in 
orthologous XyGULs from other species, nor in a B. ovatus strain possessing a simpler 
XyGUL, which were all capable of growth on tamarind XyG (Figure 2, Extended Data 
Figures ED1 & ED2), suggests BoGH9A may be largely superfluous, or plays a specialised 
role not revealed in our analysis.
A gene-specific knock-out of the ř-xylosidase BoGH31A severely reduced B. ovatus growth 
on tamarind XyG and completely abolished growth on XyGOs (Extended Data Table ED2). 
This is consistent with an essential role in removal of ř(1ў6)-xylosyl residues from the 
non-reducing-end of XyGOs (converting “ X”  units to “ G” ), to allow subsequent hydrolysis 
by the Ś-glucosidases BoGH3A and BoGH3B (removing backbone “ G”  units), and the Ś-
galactosidase BoGH2A (or another Ś-galactosidase converting “ L”ў” X” , Figure 3). The 
two ř-L-arabinofuranosidases, BoGH43A and BoGH43B, encoded by the XyGUL provide 
additional capacity to convert “ S”ў” X” , thereby enabling complete hydrolysis of 
solanaceous (e.g., tomato, eggplant, pepper, etc.) arabinogalactoxyloglucan. It is presently 
unclear if the doubling of GH3- and GH43-encoding genes in the XyGUL has any biological 
importance; the similar specific activities of BoGH3A and BoGH3B toward XyGO Ś-
glucosides suggests functional redundancy, while the apparent catalytic feebleness of 
BoGH43B toward arabinofuranosides (Extended Data Table ED1) may suggest simple loss-
of-function or evolution of a currently unresolved, orthogonal activity contrasting that of 
BoGH43A. Notably, the B. ovatus XyGUL does not encode an ř-fucosidase, as might be 
anticipated for the cleavage of the “ F”  sidechain in dicot fucogalactoxyloglucan (Figure 1). 
This may reflect compensation by exogenous or endogenous ř(1ў2)-fucosidases2 or strain 
specialisation for XyGs from individual plant sources. Indeed, XyGULs from other 
Bacteroides species encode predicted ř-fucosidases from families GH29 and GH95 (Figure 
2).
To provide further insight into XyG recognition by the keystone enzyme, we solved the 
three-dimensional structure of BoGH5A in complex with the heptasaccharide XXXG by X-
ray crystallography (Figure 4, Extended Data Table ED3). The tertiary structure comprised a 
96 residue “ Bacteroidetes-Associated Carbohydrate-binding Often N-terminal (BACON)”  
domain23 followed by a 372 residue C-terminal GH5 domain. The BACON domain 
composed an 8-stranded, immunoglobulin-like Ś-sandwich fold and represents, to our 
knowledge, the first 3-D representative of this domain family. Notably, the two molecules in 
the asymmetric unit displayed a large difference in the relative orientations of the BACON 
and GH5 domains (Figure 4A). This suggested significant flexibility in the enzyme 
(Supplementary Video V1), which is anchored on the cell surface via N-terminal lipidation; 
mutation of the predicted lipidation site (Cys1->Ala) ablates surface localization and 
hampers growth on XyG (Extended Data Figure ED3). Notably, we were unable to find 
experimental evidence in vitro that the BACON domain functions in substrate binding 
(Extended Data Figure ED4), nor that it mediates interactions with other proteins of the 
XyGUL (native PAGE data not shown). In contrast, the observation of strong XyG binding 
(Extended Data Figure ED4) by the SusD-like protein and neighboring gene product (Figure 
2, loci Bacova_02651 and Bacova_02650, respectively) indicates that, as in the archetypal 
Sus system,24 polysaccharide binding is mediated by independently encoded, non-catalytic 
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proteins of the XyGUL. Thus, the broad designation of BACON domains as “ carbohydrate-
binding” , as inferred by bioinformatics alone, may be actively misleading.23,25 In light of 
current experimental data, the most parsimonious conclusion is that the primary function of 
the BACON domain in BoGH5A may be to distance the catalytic module from the cell 
surface and confer additional mobility to the catalytic domain for attack of the 
polysaccharide.
The catalytic domain has the prototypical (ř/Ś)8 fold typical of other GH5 members and is 
most similar to Paenibacillus pabuli endo-xyloglucanase PpXG5 (PDB ID 2jep; r.m.s.d. 
1.47 Å, 330 Cř atoms) and Clostridium cellulovorans endo-glucanase EngD (PDB ID 3icg; 
r.m.s.d. 1.45 Å, 345 Cř atoms) of subfamily 4 (ref. 26). The heptasaccharide XXXG was 
observed to extend from subsites -4 to -1 in the active site cleft in both molecules of the 
asymmetric unit, with binding mediated via sugar-aromatic ring interactions and hydrogen 
bonds to both backbone and branching substrate moieties (Figure 4B, Supplementary Video 
V2). The structure of this complex is well-correlated with activity on chromogenic XyGO 
aryl Ś-glycoside substrates, which indicated that the enzyme productively harnesses the 
Xylř(1ў6) sidechains for catalysis (Extended Data Table ED1). Detailed comparison with 
the PpXG5:GXLG structure (PDB ID 2jeq)27 revealed that binding of the Ś(1ў4)-glucan 
backbone is essentially identical in the two enzymes, while differences emerge in the 
subsites that accommodate the branching sugar residues (Supplementary Video V2). 
Regardless, it is clear that a broad active site cleft engendering binding plasticity is the key 
feature allowing BoGH5A to accommodate a wide range of natural xyloglucans.
With a solid molecular understanding of the locus that confers B. ovatus with the ability to 
utilize XyG, we undertook a growth analysis of 292 individual Bacteroidetes strains isolated 
from the human gut, representing 29 different named species, to reveal the distribution of 
this trait in nature. XyG catabolism was rare, confined to 70 strains belonging to just 6 
individual, phylogenetically dispersed species (Figure 5). Of the 25 B. ovatus strains tested, 
all but one grew on tamarind XyG. Interestingly, none of the 18 strains of the closely related 
B. xylanisolvens exhibited growth on XyG, which suggested that the XyGUL has been 
independently acquired by the B. ovatus lineage. This is supported by a comparative 
genomic analysis of the XyGUL and surrounding chromosomal region in these two species 
(Extended Data Figure ED1). All ten strains tested of the more distantly related B. 
cellulosyliticus grew very well on XyG, comparable to the less proficient B. ovatus strains. 
Representing a third phylogenetic clade, the single B. fluxus strain also grew to high density 
on XyG. Of 37 strains of B. uniformis, which is closely related to B. fluxus and among the 
most abundant organisms in the microbiota of Westerners,18 33 exhibited varying capacity 
to grow on XyG. Finally, two non-Bacteroides species, Dysgonomonas gadei and D. mossii, 
which are rarely observed in humans, but are abundant in termites, also possessed the ability 
to degrade xyloglucan, revealing that this phenotype has evolved in other lineages of 
Bacteroidetes.
A comparative analysis using genomic sequence data available for many of the strains tested 
showed a perfect concordance of the presence of an orthologous XyGUL and the ability to 
utilize XyG. Thus, we revealed putative XyGULs in B. cellulosyliticus, B. uniformis, B. 
fluxus, D. mossii and D. gadei, as well as in two sequenced species, B. coprocola and B. 
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salanitronis, that were not available to directly test growth (Figures 2 & 5). These XyGULs 
were all activated during growth on XyG (Extended Data Figure ED2) and shared a similar 
overall organisation with that of B. ovatus, but did not share similar flanking regions in their 
genomes, suggesting that they were acquired via separate events. In notable contrast to a 
recent report showing that conjugative transposons are capable of mediating horizontal 
transfer of new PULs into Bacteroides genomes,28 there is no evidence of such a mechanism 
for XyGUL acquisition. Rather, the XyGUL appears to have been precisely inserted 
between two ancestral genes that are shared by all sequenced strains. For example, on the 
left side of XyGUL (Figure 2, Extended Data Figure ED1), there are only 108 bp between 
the 3 ?end of BoGH3A (Bacova_02644) and the end of the adjacent shared region; on the 
right side there are only 640 bp between the end of BoGH3B (Bacova_02659) and the 
second adjacent shared region.
To underscore the broad importance of dietary xyloglucan metabolism, we surveyed public 
metagenomic data from 250 adult humans revealing that 92% harbor at least one of five 
different Bacteroides XyGULs identified in this study (Extended Data Figure ED5). In 
contrast, the presence of a PUL involved in degrading the red algal polysaccharide 
porphyran (a component of the food product nori)29 was exceptionally rare in the same 
population, and largely confined to a small cohort of Japanese subjects. To demonstrate that 
a metabolic advantage is associated with possessing a XyGUL, a competition experiment 
was performed using germfree mice co-colonized with wild-type B. ovatus and an isogenic 
XyGUL deletion mutant. Both strains competed equally when glucose was presented as the 
sole dietary carbohydrate or when XyG was presented in a mixture of polysaccharides from 
natural vegetable sources (a diet comprising equal amounts of cooked bell pepper, eggplant, 
tomato fruit and lettuce). However, when this complex diet was removed and XyG was 
maintained as the only exogenous polysaccharide via the drinking water, the B. ovatus 
XyGUL mutant exhibited a significant fitness defect over a three-week period (Extended 
Data Figure ED6).
The prevalence of XyGs in the human diet suggests that the mechanism by which bacteria 
degrade these complex polysaccharides is highly important to human energy acquisition. 
Moreover, the rarity of XyG metabolism (Figure 5, see also ref. 8) highlights the 
significance of B. ovatus and other proficient XyG-degrading Bacteroidetes as key members 
of the human gut microbial consortium.10 Additional work will now be required to 
determine if bacteria from other groups have evolved strategies to attack this ubiquitous 
plant cell wall polysaccharide in competition or synergy with members of the 
Bacteroidetes.8,30 An unexpected finding is the specific adaptation of the glycoside 
hydrolase complement of some XyGULs to XyGs from different plant sources; this theme 
that may extend to other groups of plant polysaccharides and host mucosal glycans with 
similar or greater degrees of fine-structural variation. Following the example presented here, 
defining cohorts of enzymes and binding proteins that coordinate to target other complex 
dietary polysaccharides will be essential to fully elucidate the systems biology of gut 
microbial catabolism. Such refined mechanistic understanding will be essential in designing 
rational intervention strategies, including prebiotics, probiotics or microbial community 
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transplants, which aim to manipulate the membership, function and stability of this 
important ecosystem.4,9–12
Methods
Growth analysis of Bacteroides species & reverse genetics
The locus tags of the genes involved in the present study and the corresponding DNA 
primers used for knock-out, sequence alteration and qPCR studies are given in 
Supplementary Table S1. To construct gene deletions in B. ovatus strain ATCC 8483, a 
deletion of the gene encoding thymidine kinase (tdk; Bacova_03071) was first constructed 
using an identical strategy to that used previously for B. thetaiotaomicron.31 All subsequent 
gene deletions and sequence modifications were conducted in a Δtdk strain background by 
allelic exchange using the vector pExchange-tdk31 and primers listed in Supplementary 
Table S1. Wild-type Bacteroides ovatus ATCC 8483, all mutant derivatives and other 
Bacteroidetes species tested were grown in tryptone-yeast extract-glucose (TYG) medium, 
brain-heart infusion agar supplemented with 10% horse blood, or minimal media (MM) 
supplemented with appropriate carbohydrates as previously described.32 Antibiotics were 
added as needed: gentamicin (200 μg ml−1), erythromycin (25 μg ml−1), and 5-fluoro-2 ?-
deoxyuridine (200 μg ml−1). To prepare cells for exposure to glycans, wild-type and mutant 
B. ovatus were grown in TYG, subcultured into MM-glucose, grown to mid-exponential 
phase (OD600 0.6–0.8), then washed and resuspended in 2x MM prior to addition of the 
appropriate glycan. Xyloglucan substrates are described below and all carbohydrate stocks 
were prepared at 10 mg/ml in ddH2O and sterilized by autoclaving. All quantitative growth 
was performed at 37°C in an anaerobic chamber (Coy Manufacturing, Grass Lake, MI; 10 % 
H2, 5 % CO2 and 85 % N2) in an automated plate reading device as described previously.33 
In instances where bacterial growth data are either used to show growth curves or quantify 
differences in growth ability, strains were grown in 2–3 biological replicates. Fluorescence 
microscopy was performed on fixed B. ovatus cells grown to early exponential phase (A600 
= 0.25–0.35) in minimal medium containing a 9:1 mixture of limit XyG oligosaccharides 
(XGOs) to slightly longer (average dp = 14) XGOs (see Substrates section below). These 
conditions circumvented the reduced growth rate of the ΔGH5 mutant on limit XGOs. Cells 
were fixed in formalin and stained with a polyclonal antibody raised in rabbit against 
purified recombinant BoGH5A (Cocalico Biologicals, Reamstown, PA), following the 
method previously reported.34 The same antiserum was used to probe GH5 presence via 
Western blot.
Construction of a Bacteroidetes phylogeny
Six Bacteroidetes core genes that encode anthranilate synthase, glucose-6-phosphate 
isomerase, glycerol-3-phosphate dehydrogenase, DNA-directed RNA polymerase subunit 
beta, chorismate synthase, 3-dehydroquinate synthase and 16S rDNA were used to construct 
a phylogenetic tree. For each species, nucleotide sequences were concatentated in the same 
order, aligned using CLUSTAL-W,35 un- or poorly aligned basepairs were trimmed out 
using Gblocks,36 and the resulting alignment was used to construct a maximum parsimony 
tree with bootstraps using MEGA5.37
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Analysis of metagenomic datasets for presence of XyGULs
Human metagenomic datasets38–41 were searched by BLAST for the presence of XyGUL 
nucleotide sequences from B. ovatus (27.767 kbp), B. uniformis (28.433 kbp for PUL1, 
59.874 kbp for PUL2), B. cellulosyliticus (26.173 kbp) and B. fluxus (25.357 kbp), plus the 
porphyran utilisation PUL from B. plebeius (54.476 kbp).42 Each BLAST probe was first 
searched against the NCBI Refseq genomes database to determine the background 
thresholds for Blast hits to other sequenced genomes that do not contain a XyGUL using a 
word size of 11; this analysis failed to reveal any hits with E-values < −20, and nucleotide 
identities >90% over a length >75 bp. Thus, in subsequent searches, we considered a 
metagenome to be positive for a particular XyGUL probe if it returned two or more hits 
≥100bp in length with ≥90% identity and E-value ≤ −20. Because the most recent HMP 
metagenomic datasets assembled much larger contigs than previous studies (often aligning 
to over 20 continuous kbp of the respective XyGUL query), we considered hits in these 
datasets positive if they harbored just one hit that was ≥10 kbp with the same identity and E-
value cut-offs listed above.
Germfree mouse experiments and diets
All animal experiments were approved by the University Committee on Use and Care of 
Animals (UCUCA) at the University of Michigan and were supervised by a veterinarian. 
Germfree mouse experiments were conducted in a total of 12, 6–8 week old male and 
female Swiss Webster mice from two litters that were born 9 days apart. Mice were 
randomly assigned into 3 groups of 4 animals (each was considered to be a single biological 
replicate) by a technician who was not familiar with the project. The investigators were not 
blinded to the identities of the treatment groups during the experiment. Four mice per group 
was chosen as the sample size based on previous studies43,44 that used similar dietary 
treatment regimens and found significant alterations in competitive index using 3–7 animals 
per group (see Extended Data Figure ED6 legend for a description of statistical tests). A 
custom XyG-rich diet was constructed by pureeing equal amounts by wet weight of locally 
purchased Roma tomatoes, Romaine lettuce leaves, common eggplant with skins, and green 
bell peppers with seeds. This mixture was brought to a gentle simmer for 1 hour by heating 
in a stainless steel vessel to simulate the cooking process for these items in human foods. 
The mixture was cooled and combined at a ratio of 4:1 (wet weight mixture:dry weight 
mouse diet) with a custom polysaccharide-free rodent diet that contained sucrose as the only 
additional carbohydrate (Harlan Teklad, Madison, WI USA).45 This diet mixture was dried 
into biscuits and autoclaved prior to feeding to germfree mice. A different custom 
“ polysaccharide-free diet”  (Harlan Teklad TD.130343; 27% protein, 44.5% glucose, 15% fat 
and 8% cellulose; since B. ovatus cannot grow on cellulose it is assumed that this diet does 
not contribute usable polysaccharides) was used for longer-term feeding studies and served 
as the base diet for inoculating and stabilizing the input mixture of wild-type and ΔXyGUL 
B. ovatus strains. The relative ratios of competing B. ovatus strains were measured from 
total DNA extracted from freshly voided faecal pellets as previously described.43
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Recombinant protein production
Glycoside hydrolases—The genes of the glycoside hydrolases of this PUL were 
amplified by PCR using forward primers including Nde1 restriction sites and reverse 
primers including Xho1 restriction sites, except for GH43B, which had Sal1 restriction sites 
in the reverse primers (Supplementary Table S2). Constructs truncated to exclude predicted 
signal peptides and N-terminal lipidation sites46 were generated. The PCR products were 
digested with Nde1 and Xho1 (Nde1 and Sal1 for GH43B), and ligated into similarly 
digested pET21a vectors, followed by transformation into electrocompetent E. coli TOP10 
cells. The cells were grown in LB overnight and plasmids were extracted using the MiniPrep 
kit (Qiagen) and sequenced (Eurofins MWG Operon) to identify positive clones.
Plasmids containing the PUL hydrolase genes were transformed into E. coli BL21 (DE3) 
cells by electroporation. The cells were grown at 37 °C with shaking in Terrific Broth 
containing 100 μM ampicillin to an OD600 of 0.4–0.6 when protein expression was induced 
by addition of 0.2 mM IPTG (isopropyl Ś-D-galactopyranoside) and the temperature was 
lowered to 25 °C. Protein expression continued for 2–3 days, after which the cells were 
collected by centrifugation at 4000 g for 10 minutes. The cells were resuspended in buffer A 
(20 mM sodium phosphate pH 7.4, 500 mM sodium chloride, 20 mM imidazole) and 
disrupted by either sonication or by passing twice through a French Press, followed by 
centrifugation at 27000 g for 45 minutes. The supernatant was loaded onto 5 ml HiTrap 
IMAC FF columns (GE Healthcare) using an ÄKTA FPLC (GE Healthcare) and washed 
thoroughly with buffer A. Each protein was purified on a separate column to eliminate the 
risk of cross-contamination. Tagged proteins were eluted using a linear gradient of 0–100 % 
buffer B (20 mM sodium phosphate pH 7.4, 500 mM sodium chloride, 500 mM imidazole) 
over typically 4 column volumes. Eluted proteins were concentrated using Amicon Ultra 
centrifugal filters (Millipore) and further purified if needed by size exclusion 
chromatography on a HiPrep 26/60 Sephacryl S-200 column into 50 mM sodium phosphate, 
pH 7.0. Liquid chromatography electrospray ionisation MS was used to verify the correct 
protein mass of purified proteins as described previously (data not shown).47 To improve the 
stability and solubility of certain of the enzymes, additives were included in the protein 
stock buffers, and these were present for all assays; BoGH9A was stored in 300 mM 
ammonium sulphate, while BoGH3A was stored in 20 % glycerol.
Non-catalytic proteins and BoGH5A truncation variants—Expression vector 
pET21a (Novagen) containing BoGH5A (pBoGH5) was used for subsequent cloning of the 
BACON domain (residues 28-116), the GH5 catalytic domain (residues 117-489), and two 
active-site mutants, generating pBACON, pCAT, pBoGH5-E430A and pCAT-E430A, 
respectively. cDNA encoding the BACON and GH5 domains were amplified by PCR using 
forward primers including NdeI restriction sites and reverse primers including XhoI 
(Supplementary Table S3). Both contained a C-terminal (His)6 tag, and a TEV-cleavage site 
was added before the tag at the C-terminal end of the BACON domain insert. The catalytic 
nucleophile mutants of full-length BoGH5A and the GH5 domain were generated using Q5® 
high affinity DNA polymerase (New England BioLabs) from pBoGH5 and pCAT. The 
gene fragments corresponding to amino acids 28-519 of SusD-like Bacova_02651 and 
34-456 of Bacova_02650 gene products were amplified from B. ovatus genomic DNA by 
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PCR using forward primers including NdeI restriction sites and reverse primers including 
XhoI (Supplementary Table S3). The gene products were ligated into a modified version of 
pET-28a (EMD Biosciences) containing a recombinant tobacco etch virus (rTEV) protease 
recognition site. Heterologous protein production in E. coli BL21 and purification was 
subsequently performed essentially as described for the glycoside hydrolases of the XyGUL; 
SDS-PAGE was used to confirm the purity of the proteins.
Analytical methods
Matrix-assisted laser desorption/ionisation-time-of-flight (MALDI-TOF) 
analysis of oligosaccharides—Xylogluco-oligosaccharides (XyGOs) products were 
analysed by MALDI-TOF mass spectrometry on an LT3 Plus mass spectrometer (SAI Ltd., 
UK) operated by the MALDI Mainframe 2, Maldi Control software (version 1.03.51, SAI 
Ltd., UK). A matrix of 2,5-dihydroxybenzoic acid (DHB) (10 mg ml−1 in water) was used. 
The number of laser pulses was varied and the resulting individual spectra were summed to 
optimise signal-to-noise.
Neutral sugar analysis by High Performance Anion-Exchange 
Chromatography with Pulsed Amperometric Detection (HPAEC-PAD)—Oligo- 
and monosaccharides were analysed on a Dionex ICS-3000 HPLC system operated by 
Chromeleon software version 6.80 (Dionex) using a Dionex Carbopac PA200 column. 
Solvent A was water, solvent B 1 M sodium hydroxide and solvent C 1 M sodium acetate. 
Depending on the analytes, the following gradients were employed:
• Gradient A: 0 to 5 min, 10 % B, 2 % C; 5 to 12 min, 10 % B and a linear gradient 
from 2–30 % C; 12 to 12.1 min, 50 % B, 50 % C; 12.1 to 13 min, an exponential 
gradient (curve setting 9) of B and C back to initial conditions; 13 to 17 min, initial 
conditions.
• Gradient B: 0 to 4 min, 10 % B, 6 % C; 4 to 17 min, 10 % B and a linear gradient 
from 0–25 % C; 17 to 17.1 min, 50 % B, 50 % C; 17.1 to 18 min, an exponential 
gradient (curve setting 9) of B and C back to initial conditions; 18 to 22 min, initial 
conditions.
• Gradient C: column pre-conditioned prior to injection by −13 to −3 min, 12 % B, 
6.8 % C; −3 to 0 min, 100 % A; 0 to 25 min, 100 % A.
Substrates
The 4-nitrophenyl glycoside substrates used in this study (Glc-ř-PNP, Glc-Ś-PNP, Gal-ř-
PNP, Gal-Ś-PNP, Xyl-ř-PNP, Xyl-Ś-PNP, L- Araf-ř-PNP, L-Araf-Ś-PNP) were purchased 
from Sigma-Aldrich. 2-chloro-4-nitrophenyl oligosaccharide substrates GGGG-Ś-CNP, 
XXXG-Ś-CNP, and XLLG-Ś-CNP were synthesised as described previously48 and L-Fuc-Ś-
CNP was purchased from Carbosynth. Xyloglucan (tamarind seed), arabinoxylan, barley 
mixed linkage glucan, curdlan, galactan, gluco- and galactomannan, lichenan, 
carboxymethyl cellulose and hydroxyethyl cellulose, XXXG, isoprimeverose, cello-
oligosaccharides, and XyGOs with a higher degree of polymerization (average degree of 
polymerization = 14) were purchased from Megazyme.
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A mixture of oligosaccharides from tamarind xyloglucan was produced by dissolving 1 g of 
the polysaccharide in 100 ml water at 55 °C under vigorous stirring. The temperature was 
lowered to 37 °C and the endo-xyloglucanase BoGH5A (1 μM; vide infra) and phosphate 
buffer (to 50 mM, pH 7.0) was added, and the reaction proceeded overnight to completion, 
as assessed by HPAEC-PAD and LC-ESI-MS.49 The solution was passed through a Biogel-
P2 column using water as eluent to remove phosphate buffer. Fractions containing XyGOs 
were collected, lyophilised, and analysed by HPAEC-PAD (gradient B) to determine purity. 
The final yield was 490 mg. XLLG was prepared from tamarind XyGO mixture as described 
previously.50 A similar mixture of XyGOs was also purchased from Megazyme.
GXXG was produced by dissolving XXXG in 50 mM citrate buffer, pH 6.0, and 0.4 μM of 
the ř-xylosidase BoGH31A (vide infra) to a final substrate concentration of 40 mM. The 
reaction was incubated at 37 °C overnight, and MALDI-TOF was used to verify that the 
reaction had gone to completion. The enzyme was denatured by boiling and removed by 
centrifugation. Further purification of the oligosaccharide was not performed, so the GXXG 
prepared in this way also contained an equimolar amount of xylose.
GLLG was produced by dissolving XLLG in 20 mM citrate buffer, pH 6.0, and 0.6 μM of 
the ř-xylosidase BoGH31A (vide infra) to a final substrate concentration of 50 mM. The 
reaction was incubated at 37 °C overnight, and MALDI-TOF was used to verify that the 
reaction had gone to completion. The enzyme was denatured by boiling and removed by 
centrifugation. Further purification of the oligosaccharide was not performed; therefore 
experiments using GLLG also contained an equimolar amount of xylose.
LLG was produced by incubating GLLG (final substrate concentration 50 mM) in 50 mM 
citrate buffer, pH 6.0, with 5 μM of the Ś-glucosidase BoGH3B (vide infra). The reaction 
was incubated at 37 °C overnight, and later analysed by MALDI-TOF MS; the reaction went 
to approximately 50 % completion. The enzyme was denatured by boiling and removed by 
centrifugation. As no further purification steps were taken, the LLG prepared in this way 
also contains an equimolar amount of glucose, as well as a significant amount of the GLLG 
starting material and the monosaccharide xylose from the previous preparatory step.
Extraction of tomato and lettuce xyloglucan and production of xyloglucan 
oligosaccharides—Using a modified and scaled-up version of the protocol outlined by 
Hsieh and Harris,51 xyloglucan polysaccharide was extracted from approximately 500 g 
freshly purchased ripe tomato fruit or iceberg lettuce leaves, obtained from a local grocery 
store. Fresh plant material was homogenised in 70 % aqueous ethanol using a high-speed 
blender, collected by filtration on Miracloth and ground to a fine powder in liquid nitrogen. 
Charged polysaccharides were removed by repeated 70 % ethanol wash and filtration steps. 
Hemicellulosic polysaccharides were extracted in 6 M sodium hydroxide, containing 1 % 
sodium borohydride to prevent alkaline peeling, followed by neutralisation by addition of 
acetic acid. The neutralised solution was filtered and the filtrate was dialysed extensively to 
remove salts in deionised water. The resulting hemicellulose fractions were each incubated 
with 135 units of the xylanase CjCBM22-GH10 (Xyn10A) and 45 units of mannanase 26A 
(both purchased from NZYtech) for 16 hours at 37 °C, to hydrolyse contaminating xylan and 
mannan, respectively. The resulting xylo- and manno-oligosaccharides were removed in 
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subsequent ethanol washing steps. The final yield of tomato xyloglucan was 488 mg, and of 
lettuce xyloglucan was 560 mg.
Ethanol was added to the neutralised solution to a final concentration of 70 % to precipitate 
polysaccharides, followed by centrifugation at 4000 g for 30 minutes (or 24000 g for 10–15 
minutes). The supernatant was discarded and the pellet washed three times with 70 % 
ethanol. The final pellet was dissolved in water and loaded onto a Q Sepharose column (GE 
Lifesciences) pre-equilibrated with 10 mM imidazole (pH 7.0). Uncharged hemicellulosic 
polysaccharides were washed out by addition of three column volumes of the same buffer, 
while charged pectins were bound to the matrix. The resulting hemicellulose containing 
fractions were each incubated with 150 units of the xylanase CjCBM22-GH10 (Xyn10A) 
and 150 units of mannanase 26A (both purchased from NZYtech) for 16 hours at 37 °C, to 
hydrolyse contaminating xylan and mannan, respectively. The final yield of tomato 
xyloglucan was 170 mg, and of lettuce xyloglucan was 180 mg.
Prior to analysis by HPAEC-PAD (gradient C), the products (1 mg) were hydrolysed by 
incubation with 2 M trifluoroacetic acid (TFA) for 3 hours at 120 °C (1 ml total volume). 
Hydrolysis products were vacuum dried and resuspended in deionised water, then filtered 
(0.2 μm filter). The tomato xyloglucan comprised Glc, Xyl, Gal and Ara. The lettuce 
xyloglucan comprised Glc, Xyl, Gal and Fuc. Both materials were found to also contain 
GalA and Rha, at levels indicating pectin contamination of up to 50 %. An anion exchange 
method adapted from Hoffman et al.52 was used to remove pectins. Dry material (84 mg 
lettuce xyloglucan and 63 mg tomato XyG) was redissolved in 10 mM imidazole-HCl 
buffer, pH 7.0. This solution was mixed thoroughly with Q-sepharose fast-flow resin 
(Sigma-Aldrich), to which anionic pectic polysaccharides and any proteins bound. The flow-
through, containing neutral polysaccharides (xyloglucans and any trace remaining amounts 
of mannans and xylans), was collected by applying to a vacuum. Neutral sugar analysis 
showed a marked decrease in pectin contamination, to around 5 %.
One hundred mg of crude xyloglucan polysaccharide obtained from tomato or lettuce was 
dissolved in water (20 ml) and incubated with 0.2 μM of the BoGH5A in 50 mM phosphate 
buffer (pH 7.0) at 37 °C overnight. Ethanol was added to a final concentration of 70 % to 
precipitate remaining polysaccharides, and the soluble oligosaccharide products were 
recovered by filtration and lyophilisation of the filtrate. The XyGOs were analysed by 
HPAEC-PAD (gradient B) and MALDI-TOF. The final yield was 64 mg from the tomato 
xyloglucan and 58 mg from the lettuce XyG.
Enzyme assays
All assays were carried out at 37 °C, at or near the buffer (50 mM) and pH optima of the 
individual enzyme, unless otherwise stated. Curve fitting was performed using Origin 8 
(OriginLab). For all quantitative enzyme assays at least two technical replicates were 
performed at each assay condition (e.g., pH value, substrate concentration, etc.).
pH dependence studies—pH optima for each enzyme were determined, where possible, 
using the PNP-Gly assay, described below, except for BoGH5A for which it was determined 
using tamarind xyloglucan as substrate and the bicinchoninic acid (BCA) reducing sugar 
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assay.53,54 The buffers used are shown in Source Data Figures S1–S6. The concentrations of 
enzyme used were typically in the range 0.2 – 2 μM, unless otherwise stated.
PNP- and CNP-glycoside assays—Assays in which PNP-glycosides were used as 
substrates were monitored for the release of 4-nitrophenolate using A410, on a Cary 50 
spectrophotometer. For discontinuous assays, samples were added to an equal volume of 
200 mM Na2CO3 to terminate the reactions by raising the pH to 11.0. An extinction 
coefficient of 18500 M−1 cm−1 was used to calculate product concentration from absorbance 
values.55 For some very slow reactions, a continuous assay was used in a Cary 300 
spectrophotometer; an extinction coefficient of 10500 M−1 cm−1 (pH 7.0) was used for these 
assays.56
Assays utilising CNP-glycosides were monitored continuously for the release of 2-chloro-4-
nitrophenolate using a Cary 300 spectrophotometer (Agilent Technologies). An extinction 
coefficient of 12936 M−1 cm−1, determined from a standard curve, was used to calculate 
product concentration from A405 values.
Reducing sugar assays—Hydrolysis of polysaccharide substrates was measured by an 
increase in reducing sugars, using the 3,5-dinitrosalicylic acid reducing sugar assay 
(DNSA)57 versus a standard curve of Glc (1–6 mM). Reaction samples were added to an 
equal volume of DNSA reagent to terminate the reaction, and the colour was developed by 
boiling for 20 minutes, prior to measuring A575 on a Cary 50 spectrophotometer (Agilent 
Technologies).
Assays for the detection of specific monosaccharide release—A linked 
galactose dehydrogenase/galactose mutarotase assay (Megazyme) was used to quantify the 
release of galactose or arabinose from xyloglucan or XyGOs. The release of galactose or 
arabinose led to the stoichiometric reduction of NAD+ to NADH, giving an increase in A340 
(ŝ 6230 M−1 cm−1 at pH 7.0),56 which was read continuously using a Cary 300 
spectrophotometer.
A second linked assay (Glucose/Mannose/Fructose detection kit, Megazyme) was used to 
quantify the release of glucose monosaccharides. The protocol provided in the 
manufacturer’ s instructions was modified for use as a continuous assay. The release of a 
glucose monosaccharide corresponds stoichiometrically with the reduction of a molecule of 
NADP+ to NADPH, which leads to an increase in A340 (ŝ 6220 M−1 cm−1),56 observed 
continuously using a Cary 300 spectrophotometer. Reactions were carried out in the 
triethylamine buffer (pH 7.6) provided with the assay kit.
Assays using HPAEC-PAD analysis—Enzymatic reactions on xylogluco- and cello-
oligosaccharides were performed in 50 μl of 50 mM buffer and were stopped by addition of 
2 μl of 5 M sodium hydroxide prior to HPAEC-PAD analysis. Gradient A was used for 
reactions with XXXG or XLLG and Gradient B was used for assays against xyloglucan 
polysaccharides and cello-oligosaccharides.
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Affinity gel electrophoresis
Affinity gel electrophoresis was performed for 90 min at room temperature on non-
denaturing 10% (w/v) polyacrylamide gels, essentially as previously described.58
Isothermal titration calorimetry (ITC)
Isothermal titration calorimetry (ITC) was performed essentially as previously 
described59,60 using a MicroCal VP-ITC calorimeter. Proteins were dialysed into 20 mM 
HEPES 100 mM NaCl pH 7.0 and polysaccharides were dissolved in the dialysis buffer 
separately. The proteins (20–40 μM) were placed in the sample cell, and after the 
temperature equilibrated to 25°C, a first injection of 2 μL was performed followed by 25 
subsequent injections of 10 μL of either polysaccharide (1–2.5 mg/mL). The solution was 
stirred at 280 rpm and the resulting heat of reaction was recorded. Data were analysed using 
the Origin software program.
Structural biology
BoGH5A Preparation for Crystallisation—Typically ~ 5 g of cell paste were 
resuspended in 5x volumes of Buffer C (50 mM HEPES pH 7.0, 0.5 M NaCl, 30 mM 
imidazole) and cells were lysed using three 15 s pulses of sonication at maximum amplitude 
using an MSE Soniprep 150 sonicator. Cell debris was removed by centrifugation at 38000 g 
for 30 minutes at 4°C. The supernatant was applied to a 5 ml GE Healthcare HiTrap Nickel 
NTA column that had been equilibrated in Buffer C at 10°C using an Äkta Xpress 
purification system. The column was washed with 5 column volumes of Buffer C before a 
100 ml gradient of Buffer D (Buffer C + 300 mM imidazole) was applied to elute the 
protein. Fractions of 1.6 ml were collected along the gradient. Peak fractions containing the 
enzyme were pooled and concentrated using a 30 kDa molecular weight cut off Sartorius 
concentrator by centrifugation at 5 g to a volume of approximately 1 ml. The protein was 
then applied to a GE Healthcare 16/60 HiLoad Superdex 200 column, which had been 
equilibrated with gel filtration buffer (10 mM Tris pH 8.0, 250 mM NaCl). Following a void 
volume of 45 ml, 1.6 ml fractions were collected. Fractions containing BoGH5A were 
combined and buffer exchanged into 10 mM Tris pH 8.0, 50 mM NaCl before final 
concentration to 53 mg ml−1 as judged by absorption at 280 nm using an extinction 
coefficient of 79300 M−1 cm−1 and a molecular weight of 51674 Da.
To prepare the protein:XyGO complex 53 mg ml−1 BoGH5A was mixed with 100 mM 
XyGO (10 % XLXG, 90 % XXLG) to give final concentrations of 48 mg ml−1 protein and 
10 mM XyGO.
Structure solution and refinement—Crystallisation trials were set up in sitting drops 
using a Mosquito robot (TTP Labtech). Diffraction-quality crystals were obtained in 0.1 M 
Bis-Tris pH 6.5, 20 % w/v polyethylene glycol monomethyl ether 5,000. Crystals were cryo-
protected by soaking in mother liquor supplemented with 20 % (v/v) ethylene glycol for 30 
seconds prior to flash freezing in liquid N2.
X-ray diffraction data were collected at the Diamond Synchrotron; station I03. Data were 
processed using XDS.61 The structure was determined by molecular replacement in 
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PHASER62 using chain A of the Paenibacillus pabuli GH5 (PDB ID 2jep) as the search 
model. Two molecules were located in the asymmetric unit with log-likelihood gains of 99 
and 364 for the first and second molecules respectively. The crucial step in model building 
was to harness 3 cycles of phase improvement, including NCS averaging, in PARROT63, 
prior to model construction using ARPwARP64. Subsequent model building and refinement 
was performed using REFMAC565 and COOT66, respectively, with the validity of the 
model monitored using MolProbity67 prior to deposition (PDB ID 3zmr).
Extended Data
Figure ED1. 
Evolution of the genomic region containing the XyGUL and corresponding growth on XyG 
as a sole carbon source. a. Genomic organisation of 11 representative strains from 3 
different species of Bacteroides. b. Growth of these strains on tamarind XyG with glucose 
and xylose as controls (average of n=2 growths per strain). The observation that one B. 
ovatus strain (SD CMC 3f) lacks a corresponding XyGUL, as do all B. xylanisolvens (the 
closest cultured relative of B. ovatus), suggests that the XyGUL entered B. ovatus after it 
diverged. Also note that two other unrelated flanking PULs show variable presence at this 
locus, suggesting that it is a ‘ hotspot’  for PUL evolution.
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Figure ED2. 
Activation of putative XyGULs in Bacteroidetes isolates via growth on XyG. a. Sentinel 
(ref. 7) susC-like gene expression (n=3, expression measurements from separately grown 
cultures relative to a minimal medium plus glucose control). b. Growth profiles of the 
corresponding strains in medium containing tamarind XyG with glucose and xylose as 
controls (average of n=2 growths per strain). Error bars represent standard errors of the 
mean.
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Figure ED3. 
Cell-surface localisation of BoGH5A and effect of localisation on B. ovatus growth. a. 
staining of fixed wild-type and mutant B. ovatus strains. b. Western blot indicating that 
BoGH5A is still produced in the C1A lipidation site mutant, albeit in multiple degraded 
forms. c. Growth of wild-type (positive control), ΔBoGH5A (negative control) and 
BoGH5A-C1A strains on tamarind XyG. The BoGH5A-C1A mutant exhibits ~2.6-fold 
slower exponential growth than the wild-type. Vertical error bars on each curve indicate the 
standard deviation of the mean (n=3 replicates). The residual growth ability of the BoGH5A-
C1A strain, despite mis-localization, is unlikely to be explained by the presence of BoGH5A 
enzyme accumulation in the supernatant, which was only detected by Western blot for wild-
type bacteria expressing BoGH5A on the cell surface. Detection of BoGH5A in panels a and 
b was achieved with a rabbit polyclonal antibody raised against the recombinant protein 
produced in E. coli. Panels a nd b show representative data two experiments each that 
yielded very similar results.
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Figure ED4. 
Non-catalytic interaction of BoGH5A variants, SusD-like Bacova_02651 and Bacova_02650 
of the XyGUL with polysaccharides. a. SDS-PAGE of recombinant proteins (representative 
data from at least three preparations for each protein is shown). b. Affinity gel 
electrophoresis (representative data from at least two gels for each experimental condition). 
c. Isothermal titration calorimetry (ITC); the upper graph in each pair shows the raw heat 
during titration, while the lower graph shows the integrated heats after correction. d. 
Association constants and thermodynamic parameters obtained from ITC data. Bovine 
serum albumin (BSA) was used as non-interacting negative control protein. Other protein 
names were abbreviated as follows: BACON, residues Cys1-Tyr97 corresponding to the 
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BACON domain of BoGH5A; Bacova_02651, SusD-like XyGUL gene product; 
Bacova_02650, SusE-positioned XyGUL gene product; BoGH5A E430A, full-length (Cys1 
to Asn470) catalytic nucleophile mutant of BoGH5A; CAT E430A, catalytic nucleophile 
mutant of the BoGH5A catalytic domain only (Ser98 to Asn470). Reducing-sugar assays 
confirmed the catalytic mutants had no detectable hydrolytic activity on xyloglucan (data 
not shown), while an active variant (i.e., E430) of CAT had a 2-fold higher specific activity 
than the full-length, wild-type BoGH5A at saturating xyloglucan concentrations (0.5 – 3 
mM).
Figure ED5. 
Abundance of Bacteroides XyGULs in human from a survey of metagenomic sequencing 
data from a total of 250 adult human samples (211 healthy, 27 ulcerative colitis, 12 Crohn’ s 
Disease; see Methods for references). Datasets were individually queried by BLAST using 
the entire XyGUL nucleotide sequence from each of the four Bacteroides species listed at 
the top (cf. Fig. 2) and a PUL involved in degrading the red algal polysaccharide porphyran. 
Each horizontal line represents the presence or absence of a hit in a single individual. The 
leftmost column summarizes the total XyGUL content in each person (annotated according 
to the color key in the upper right corner). The XyGUL frequency across all 250 samples is 
shown at the bottom for each condition. The graph at the far right illustrates the variation in 
sequencing depth for each sample/study: black lines show the average depth in 
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megabasepairs (Mbp) for each study; the light gray line shows the depth for each individual 
sample.
Figure ED6. 
Presence of the XyGUL confers a fitness advantage to B. ovatus in the presence of dietary 
xyloglucan, but only when other dietary polysaccharides are eliminated. a. MALDI analysis 
of BoGH5A-digested alkaline extract from a custom mouse diet that contained a large 
amount of xyloglucan from natural vegetable sources (equal amounts of cooked bell pepper, 
eggplant, tomato fruit and lettuce; see Methods), indicating the presence of both solanaceous 
(arabinogalacto)xyloglucan and (fucogalacto)xyloglucan. b. qPCR analysis of XyGUL 
sentinel gene (ref. 7) expression in wild-type B. ovatus grown on extracted polysaccharides 
from the XyG-rich custom diet, demonstrating that it significantly activates XyGUL 
expression over a glucose control (error bars show the standard deviation of the mean of 
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three biological replicates for both growth conditions). c. In vitro growth of wild-type and 
ΔXyGUL B. ovatus strains in the polysaccharide extract from the XyG-rich diet, including 
glucose and tamarind XyG as positive and negative control substrates, respectively. 
Compared to growth on tamarind XyG (middle panel), the incomplete growth defect of 
ΔXyGUL mutant on the food extract (right panel) indicates that the food contains other 
polysaccharides that are accessible by B. ovatus. Vertical error bars on each curve indicate 
the standard deviation of the mean of 3 replicates. d. In vivo competition of wild-type and 
ΔXyGUL B. ovatus strains in mice consuming various amounts of dietary XyG. All mice 
were initially fed a synthetic diet containing glucose as the sole digestible carbohydrate for 1 
week and then gavaged with a 7:3 ratio of ΔXyGUL:WT (based on independent culture 
optical densities, total of ~108 viable B. ovatus) and the communities were allowed to 
equilibrate for 3 days. Despite the initial ratio biased in favour of the ΔXyGUL strain, the 
communities equilibrated in the range 5:5 – 4:6, but thereafter remained stable while mice 
were maintained on the XyG-free diet (blue boxes in three competition plots). Subsequent to 
community stabilization, three different dietary regimens were analysed. Left panel: Mice 
were maintained on the control diet (glucose only, devoid of XyG) between days 5–37, but 
switched to water containing 0.25% purified XyG for days 15–37 (gray box); Middle panel: 
Mice were switched to a xyloglucan-rich, custom diet from natural food sources while 
simultaneously drinking water containing 0.25% purified XyG (green box). These mice 
were then switched to the glucose-only, XyG-free control diet while remaining on water 
containing 0.25% XyG (gray box); Right panel: Mice were switched to the XyG-rich diet 
between days 3–15 but given normal water (yellow box), these mice were not continued 
further on any dietary regimen. Maintenance on either XyG food/XyG water (middle panel) 
or XyG food only (right panel) does not exert a measurable fitness pressure on the 
competing WT and ΔXyGUL strains. However, when the complex natural food 
polysaccharides were withheld while 0.25% XyG was maintained in water, a clear fitness 
pressure was observed via the significant, sequential reduction of the ΔXyGUL mutant 
between 15–37 days. These data suggest that although the XyGUL confers an advantage to 
B. ovatus by broadening its substrate range to include XyG, the presence of alternative 
oligo- and polysaccharides (e.g., other hemicelluloses, pectins) in a complex vegetable-
based diet is nonetheless sufficient to support strains lacking this locus in vivo. Each data 
point is the mean abundance of the indicated strain in 4 separate mice and error bars 
represent one standard deviation. Measurements conformed to a normal distribution based 
on the observation that 67% of all assay values were within one standard deviation of their 
respective means. Asterisks indicate statistically significant alterations (p < 0.01; student’ s t 
test, one-tailed, paired) in strain abundance relative to the day 15 samples, which 
immediately preceded the diet switch aimed at isolating XyG as the sole exogenous 
polysaccharide.
Table ED1
Summary of kinetic analyses of XyGUL glycoside hydrolases.*
Enzyme Substrate b kcat (s−1)† Km (mM)‡ kcat/Km (s−1 mM−1)‡,§ Assay||
BoGH2A Gal-Ś-PNP 4.0 ± 0.092 0.087 ± 0.0074 46.0 PNP
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Enzyme Substrate b kcat (s−1)† Km (mM)‡ kcat/Km (s−1 mM−1)‡,§ Assay||
BoGH3A Glc-Ś-PNP Trace activity PNP
cellobiose Trace activity Glc-kit
cellotetraose 65.0 ± 3.81 2.49 ± 0.42 21.3 Glc-kit
cellohexaose 0.62 ± 0.15 0.698 ± 0.52 0.90 Glc-kit
GLLG n.d.¶ n.d. 0.15 Glc-kit
GXXG n.d. n.d. 3.41 Glc-kit
BoGH3B Glc-Ś-PNP 1.74 ± 0.21 0.155 ± 0.039 11.2 PNP
Gal-Ś-PNP Trace activity PNP
cellobiose 1.57 ± 0.11 0.68 ± 0.16 2.3 Glc-kit
cellotetraose 3.99 ± 0.31 0.23 ± 0.060 17.3 Glc-kit
cellohexaose 4.91 ± 0.71 0.47 ± 0.21 10.4 Glc-kit
GLLG n.d. n.d. 0.18 Glc-kit
GXXG n.d. n.d. 3.34 Glc-kit
BoGH5A XXXG-Ś-CNP 10.5 ± 0.14 0.036 ± 0.0027 291.7 CNP
XLLG-Ś-CNP 11.1 ± 1.13 0.145 ± 0.024 76.5 CNP
GGGG-Ś-CNP 0.12 ± 0.025 3.59 ± 1.27 0.034 CNP
Tamarind XyG 435.3 ± 25.6 0.82 ± 0.17 mg 
ml−1
534.0 s−1 mg−1 ml DNSA
Lettuce XyG n.d. n.d. 543.1 s−1 mg−1 ml DNSA
Tomato XyG n.d. n.d. 501.5 s−1 mg−1 ml DNSA
BoGH9A Tomato XG Active (MALDI-MS data) DNSA
BoGH31A Xyl-ř-PNP 1.60 ± 0.031 7.7 ± 0.273 0.21 PNP
Glc-ř-PNP 0.071 ± 0.015 31.8 ± 5.1 0.0022 PNP
XXXG 32.6 ± 2.1 0.223 ± 0.046 146.2 HPLC
XLLG 31.0 ± 1.9 0.378 ± 0.075 82.0 HPLC
Isoprimeverose 1.78 ± 0.21 38.1 ± 7.1 0.047 Glc-kit
BoGH43A L-Araf-ř-PNP 0.057 ± 0.001 0.71 ± 0.03 0.081 PNP
Xyl-Ś-PNP 0.26 ± 0.005 6.58 ± 0.21 0.039 PNP
Tomato XyGOs n.d. n.d. 0.013 s−1 mg−1 ml GDh-kit
Tomato XyG Active GDh-kit
BoGH43B L-Araf-ř-PNP 5.0 × 10−4 ± 8.1 × 10−5 6.6 ± 2.3 7.6 × 10−5 Cont. assay
Tomato XyGOs n.d. n.d. 0.0024 s−1 mg−1 ml GDh-kit
Tomato XyG Active GDh-kit
*pH-rate profiles, full kinetic data plots, and carbohydrate product analyses are available in Supplementary Figures S1–S20 
for all enzymes.
†
Data is only given for those substrates on which a given enzyme was active. For example, BoGH5A and BoGH9A were 
not active on arabinoxylan, barley mixed-linkage glucan, curdlan, galactan, gluco- and galactomannan, lichenan, 
carboxymethyl cellulose, or hydroxyethyl cellulose. The full panel of chromogenic and natural substrates against which 
enzymes were tested is described in the Methods (Supplementary Information).
‡
These units apply to all values in the column, unless otherwise stated. Standard errors of means are indicated.
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§
For substrates for which individual kcat and Km values are not reported, kcat/Km values were obtained from linear curve 
fitting to initial rate data in the [S] Զ Km(apparent) regime, where the standard Michaelis-Menten equation reduces to vo 
= kcat[E][S]/Km
¶
n.d.: not determined.
Table ED2
Growth of mutant B. ovatus strains on xyloglucan relative to wild-type B. ovatus 8384.
Strain Relative Growth* (%) Relative Rate (∆A600/∆time) Relative Lag (∆timeMutant/∆timeWT)
ΔGH5 tamarind xyloglucan No Growth
dp14 tamarind xyloglucan 139 ± 17† 2.2 ± 0.2† 1.2 ± 0.1
GH5-digested tamarind xyloglucan 70 ± 9 0.6 ± 0.2‡ 1.2 ± 0.2
XGOs (Megazyme) 71 ± 6‡ 0.6 ± 0.1† 1.3 ± 0.3
ΔGH9 tamarind xyloglucan 119 ± 11 1.2 ± 0.2 1.0 ± 0.1
dp14 tamarind xyloglucan 114 ± 18 0.9 ± 0.1 1.1 ± 0.1
GH5-digested tamarind xyloglucan 105 ± 6 1.0 ± 0.1 1.3 ± 0.3
XGOs (Megazyme) 95 ± 13 0.9 ± 0.1 1.2 ± 0.2
ΔGH31 tamarind xyloglucan 18 ± 2† 0.06 ± 0.05† 3.3 ± 0.8†
dp14 tamarind xyloglucan No Growth
GH5-digested tamarind xyloglucan No Growth
XGOs (Megazyme) No Growth
*Growth conditions are described in Methods. Relative growth values are average percent of wild-type B. ovatus 8384 
growth density. No growth was defined as an increase of OD600 < 0.05, measured from the initial baseline to the 
maximum achieved. Standard errors of mean values for three biological replicates are indicated.
†
p value ≤0.05 as determined by unpaired t-test
‡
p value = 0.05–0.1 as determined by unpaired t-test
Table ED3
Data collection and refinement statistics for BoGH5A:XXXG complex.
BoGH5A:XXXG (PDB ID 3zmr)
Data collection
Space group P21
Cell dimensions
 a, b, c (Å) 46.8, 147.2, 84.1
 ř, Ś, ś(°) 90.0, 92.8, 90.0
Resolution (Å) 72.99 - 1.43 (1.47 – 1.43)*
Rmerqe 0.058 (0.575)
I/ūI 12.2 (2.2)
Completeness (%) 99.5 (99.8)
Redundancy 2.1 (2.0)
Refinement
Resolution (Å) 72.99 - 1.43
No. reflections (Work/Free) 197432/10458
Rwork/Rfree 0.12/0.16
No. atoms
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BoGH5A:XXXG (PDB ID 3zmr)
 Protein 7403
 Ligand/ion 226
 Water 1342
Avg B-factors
 Protein 19
 Ligand/ion 38
 Water 32
R.m.s. deviations
 Bond lengths (Å) 0.011
 Bond angles (°) 1.46
*Values in parentheses are for highest-resolution shell.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Representative structures of XXXG- and XXGG-type xyloglucans. a. XXXG-type 
xyloglucans, comprised of a Glc4Xyl3 repeating motif with variable branch extensions (bold 
residues). Tamarind seed xyloglucan and primary cell wall xyloglucans (e.g. from lettuce 
leaves) are distinguished by the absence of fucose in the former. b. XXGG-type 
xyloglucans, comprised of Glc4Xyl2 repeating motif. These xyloglucans are common to 
solanaceous species (e.g. tomato) and are typified by branches extended with 
arabinofuranosyl residues. Standard single-letter abbreviations5 for designating backbone 
decorations are shown.
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Figure 2. 
Structure of the B. ovatus xyloglucan utilization locus and evolution in the Bacteroidetes 
lineage. a. PULs with partial homology and synteny; homologous genes are connected by 
gray bars and flanking genes lacking synteny are shown as semi-transparent. b. PULs with 
partial homology, but lacking overall synteny. Extended Data Figure ED2 provides 
transcriptional evidence that each of these gene clusters is responsive to growth on XyG.
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Figure 3. 
The concerted action of XyGUL gene products in the degradation of xyloglucans. Most 
probable sequential pathways for the hydrolysis of (galacto)xyloglucan (a) and 
(arabinogalacto)xyloglucans (b) based on enzyme kinetic data, product analysis, and 
selected gene knock-out studies (see Fig. 1 for XyG motif abbreviations). Enzymes are 
represented as circles, colour-coded as in panel c: Rainbow, endo-xyloglucanase BoGH5A; 
tan, endo-xyloglucanase BoGH9A; orange, ř-xylosidase BoGH31A; turquoise ř-L-
arabinofuranosides BoGH43A and/or BoGH43B; yellow Ś-galactosidase BoGH2; dark blue 
Ś-glucosidases BoGH3A and/or BoGH3B. c. Model of enzyme localisation by analogy with 
the archetypal Sus locus4 and based on inference of N-terminal lipoprotein modification 
from protein sequence data.
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Figure 4. 
Structural biology of BoGH5A. a. Tertiary structure; the two conformations observed in 
crystallo have been oriented relative to the N-terminal, membrane-anchored BACON 
domain (see also Supplementary Video V1). b. Wall-eyed stereo view of the binding of 
XXXG in the -4 to -1 subsites (see also Supplementary Video V2). The wireframe 
represents an unbiased 2Fo-Fc map (contoured at 0.3 electrons per Å3) obtained using 
phases calculated from the best model prior to the incorporation of any ligand in refinement.
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Figure 5. 
Growth of different human gut-resident Bacteroidetes on xyloglucan. Each point represents 
the normalized maximum growth OD600 achieved by each strain after 4 d of growth in 
minimal medium with tamarind XG as the sole carbon source (average of n=2 independent 
growth analyses per strain). The inset shows a phylogenetic tree constructed from fully 
sequenced strains of the species shown; those labeled in red have the ability to grow on 
xyloglucan as sole carbon source and those labeled in green have PULs similar to B. ovatus 
XyGUL but were not tested for growth on XG. Bootstrap values based on 1000 replicate 
trees are indicated.
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